Sita Bio

Sita Bio is a London-based biotech developing a first-trimester biology platform to investigate embryo implantation failure and recurrent miscarriage.

The company combines endometrial phenotyping and molecular state mapping with human uterine models incorporating hormone-responsive epithelium, stromal ECM, perfusable vasculature and immune elements.

Its long-term goal is to enable precision protocol selection for IVF clinics and to identify therapeutic candidates for early pregnancy loss.